AAAAAA
Results: 1-25/40
Authors:
RITZKE C
STIEBER P
UNTCH M
NAGEL D
EIERMANN W
FATEHMOGHADAM A
Citation: C. Ritzke et al., ALKALINE-PHOSPHATASE ISOENZYMES IN DETECTION AND FOLLOW-UP OF BREAST-CANCER METASTASES, Anticancer research, 18(2B), 1998, pp. 1243-1249
Authors:
REITER W
STIEBER P
SCHMELLER N
NAGEL D
SCHAMBECK C
FATEHMOGHADAM A
Citation: W. Reiter et al., IS FREE PROSTATE-SPECIFIC ANTIGEN HELPFUL IN THE DIFFERENTIAL-DIAGNOSIS OF BENIGN HYPERPLASIA AND CANCER OF THE PROSTATE, Tumor biology, 18(2), 1997, pp. 80-87
Authors:
REITER W
STIEBER P
SCHMELLER N
NAGEL D
HOFMANN K
FATEHMOGHADAM A
Citation: W. Reiter et al., TOTAL AND FREE PSA - A METHODICAL AND CLINICAL-EVALUATION OF 5 ASSAYS, Anticancer research, 17(6D), 1997, pp. 4759-4765
Authors:
REITER W
STIEBER P
SCHMELLER N
NAGEL D
FATEHMOGHADAM A
Citation: W. Reiter et al., ALPHA(1)-ANTICHYMOTRYPSIN-PSA (ACT-PSA) - A USEFUL MARKER IN THE DIFFERENTIAL-DIAGNOSIS OF BENIGN HYPERPLASIA AND CANCER OF THE PROSTATE, Anticancer research, 17(6D), 1997, pp. 4767-4770
Authors:
REITER W
STIEBER P
REUTER C
NAGEL D
CRAMER C
PAHL H
FATEHMOGHADAM A
Citation: W. Reiter et al., PROGNOSTIC VALUE OF PREOPERATIVE SERUM LEVELS OF CEA CA-19-9 AND CA-72-4 IN GASTRIC-CARCINOMA, Anticancer research, 17(4B), 1997, pp. 2903-2906
Authors:
REITER W
STIEBER P
REUTER C
NAGEL D
LAUWERNER U
PAHL H
FATEHMOGHADAM A
Citation: W. Reiter et al., PREOPERATIVE SERUM LEVELS OF CEA AND CA-19-9 AND THEIR PROGNOSTIC-SIGNIFICANCE IN COLORECTAL-CARCINOMA, Anticancer research, 17(4B), 1997, pp. 2935-2938
Authors:
MEIER W
STIEBER P
HASHOLZNER U
GROPP M
FATEHMOGHADAM A
Citation: W. Meier et al., PROGNOSTIC-SIGNIFICANCE OF CA125 IN PATIENTS WITH OVARIAN-CANCER AND SECONDARY DEBULKING SURGERY, Anticancer research, 17(4B), 1997, pp. 2945-2947
Authors:
MEIER W
BAUMGARTNER L
STIEBER P
HASHOLZNER U
FATEHMOGHADAM A
Citation: W. Meier et al., SIGNIFICANCE OF TUMOR-MARKER DETERMINATIONS IN THE PRIMARY THERAPY OFOVARIAN-CANCER, Anticancer research, 17(4B), 1997, pp. 2949-2951
Authors:
MEIER W
STIEBER P
HASHOLZNER U
BAUMGARTNER L
FATEHMOGHADAM A
Citation: W. Meier et al., PROGNOSTIC-SIGNIFICANCE OF SQUAMOUS-CELL CARCINOMA (SCC) ANTIGEN IN PRIMARY ADVANCED AND RECURRENT CERVICAL-CARCINOMA, Anticancer research, 17(4B), 1997, pp. 2959-2962
Authors:
WAIDELICH R
JANSEN HM
STIEBER P
SCHMELLER N
LAMERZ R
WERDAN K
FATEHMOGHADAM A
Citation: R. Waidelich et al., SCREENING FOR PROSTATIC-CARCINOMA WITH PROSTATE-SPECIFIC ANTIGEN, Anticancer research, 17(4B), 1997, pp. 2979-2981
Authors:
REITER W
STIEBER P
SCHMELLER N
NAGEL D
JANSEN HM
SCHAMBECK C
FABRICIUS PG
PAHL H
MATTES M
CONSTABEL H
FATEHMOGHADAM A
Citation: W. Reiter et al., THE RATIO OF FREE TO TOTAL PROSTATE-SPECIFIC ANTIGEN - AN ADVANTAGEOUS ADDITION IN THE DIFFERENTIAL-DIAGNOSIS OF BENIGN HYPERPLASIA AND CANCER OF THE PROSTATE, Anticancer research, 17(4B), 1997, pp. 2987-2991
Authors:
MEIER W
BAUMGARTNER L
STIEBER P
HASHOLZNER U
FATEHMOGHADAM A
Citation: W. Meier et al., CA125 BASED DIAGNOSIS AND THERAPY IN RECURRENT OVARIAN-CANCER, Anticancer research, 17(4B), 1997, pp. 3019-3020
Authors:
POLEY S
STIEBER P
NUSSLER V
PAHL H
FATEHMOGHADAM A
Citation: S. Poley et al., EVALUATION OF SERUM NEURAL CELL-ADHESION MOLECULE AS A PROGNOSTIC MARKER IN MULTIPLE-MYELOMA, Anticancer research, 17(4B), 1997, pp. 3021-3024
Authors:
POLEY S
STIEBER P
NUSSLER V
PAHL H
FATEHMOGHADAM A
Citation: S. Poley et al., SERUM THYMIDINE KINASE IN NON-HODGKIN LYMPHOMAS WITH SPECIAL REGARD TO MULTIPLE-MYELOMA, Anticancer research, 17(4B), 1997, pp. 3025-3029
Authors:
SCHAMBECK CM
STIEBER P
SCHMELLER N
HOFMANN K
PAHL H
FATEHMOGHADAM A
Citation: Cm. Schambeck et al., CYFRA-21-1 QUANTITY MEASUREMENT IN THE URINE OF PATIENTS WITH CARCINOMA OF THE URINARY-BLADDER AND TRACT, Anticancer research, 17(4B), 1997, pp. 3063-3065
Authors:
WICK M
WICK M
HEBERGER S
SIMON H
FATEHMOGHADAM A
Citation: M. Wick et al., QUALITY STUDIES FOR PROTEIN-ANALYSIS OF I GG PREPARATIONS, Infusionstherapie und Transfusionsmedizin, 23, 1996, pp. 55-59
Authors:
SCHMITT UM
STIEBER P
HASHOLZNER U
PAHL H
HOFMANN K
FATEHMOGHADAM A
Citation: Um. Schmitt et al., METHODOLOGICAL AND CLINICAL-EVALUATION OF 2 AUTOMATED ENZYMATIC IMMUNOASSAYS AS COMPARED WITH A RADIOIMMUNOASSAY FOR NEURON-SPECIFIC ENOLASE, European journal of clinical chemistry and clinical biochemistry, 34(8), 1996, pp. 679-682
Authors:
STIEBER P
WOLLENBERG B
SCHMITT UM
VONJAN N
HOFMANN K
FATEHMOGHADAM A
Citation: P. Stieber et al., CLINICAL RELEVANCE OF TUMOR-MARKERS IN HE AD AND NECK SQUAMOUS-CELL CARCINOMAS, Tumordiagnostik & Therapie, 17(4), 1996, pp. 116-121
Authors:
HASHOLZNER U
STIEBER P
DIENEMANN H
FIEBIG M
FABRICIUS PG
MELER W
REUTER C
FATEHMOGHADAM A
Citation: U. Hasholzner et al., CHROMOGRANIN-A IN BENIGN AND MALIGNANT DISEASES, Tumordiagnostik & Therapie, 17(3), 1996, pp. 82-87
Authors:
REITER W
STIEBER P
SCHMELLER N
NAGEL D
PAHL H
MATTES M
FABRICIUS PG
FATEHMOGHADAM A
Citation: W. Reiter et al., FREE PSA - A USEFUL MARKER IN THE DIFFERENTIAL-DIAGNOSIS OF BENIGN HYPERPLASIA AND CANCER OF THE PROSTATE, Tumordiagnostik & Therapie, 17(3), 1996, pp. 88-92
Authors:
STIEBER P
SCHMELLER N
SCHAMBECK C
HOFMANN K
REITER W
HASHOLZNER U
FATEHMOGHADAM A
Citation: P. Stieber et al., CLINICAL RELEVANCE OF CYFRA-21-1, TPA-IRMA AND TPA-LIA-MAT IN URINARY-BLADDER CANCER, Anticancer research, 16(6B), 1996, pp. 3793-3798
Authors:
WOLLENBERG B
JAN V
SCHMIT UM
HOFMANN K
STIEBER P
FATEHMOGHADAM A
Citation: B. Wollenberg et al., CYFRA-21-1 IS NOT SUPERIOR TO SCC ANTIGEN AND CEA IN HEAD AND NECK SQUAMOUS-CELL CANCER, Anticancer research, 16(5B), 1996, pp. 3117-3124
Authors:
HASHOLZNER U
BAUMGARTNER L
STIEBER P
MEIER W
REITER W
PAHL H
FATEHMOGHADAM A
Citation: U. Hasholzner et al., CLINICAL-SIGNIFICANCE OF THE TUMOR-MARKERS CA-125-II AND CA-72-4 IN OVARIAN-CARCINOMA, International journal of cancer, 69(4), 1996, pp. 329-334
Authors:
SCHAMBECK CM
BARTL R
HOCHTLENVOLLMAR W
WICK M
LAMERZ R
FATEHMOGHADAM A
Citation: Cm. Schambeck et al., CHARACTERIZATION OF MYELOMA CELLS BY MEANS OF LABELING INDEX, BONE-MARROW HISTOLOGY, AND SERUM BETA(2)-MICROGLOBULIN, American journal of clinical pathology, 106(1), 1996, pp. 64-68
Authors:
REITER W
STIEBER P
REUTER C
NAGEL D
CRAMER C
FATEHMOGHADAM A
Citation: W. Reiter et al., SENSITIVITY AND PROGNOSTIC-SIGNIFICANCE OF CA-72-4, CEA, AND CA-19-9 SERUM LEVELS IN UNTREATED PATIENTS WITH GASTRIC-CANCER, Tumordiagnostik & Therapie, 16(3), 1995, pp. 98-101